DMS 114 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "DMS 114" in Chinese language version.

refsWebsite

Global rank Chinese rank

7nih.gov

4^th place

5^th place

4doi.org

2^nd place

23^rd place

3web.archive.org

1^st place

doi.org

Kajimoto, S; Horie, M; Manabe, H; Masuda, Y; Shibayama-Imazu, T; Nakajo, S; Gong, XF; Obama, T; Itabe, H; Nakaya, K. A tyrosine kinase inhibitor, beta-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity.. Biochimica et biophysica acta. 2008-01, 1782 (1): 41–50 [2019-12-21]. PMID 18078828. doi:10.1016/j.bbadis.2007.11.004. （原始内容存档于2019-12-21）.
Pettengill, OS; Sorenson, GD; Wurster-Hill, DH; Curphey, TJ; Noll, WW; Cate, CC; Maurer, LH. Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung.. Cancer. 1980-03-01, 45 (5): 906–18 [2019-12-21]. PMID 6266631. doi:10.1002/1097-0142(19800301)45:5<906::aid-cncr2820450513>3.0.co;2-h. （原始内容存档于2019-12-21）.
Improgo, MR; Johnson, CW; Tapper, AR; Gardner, PD. Bioluminescence-based high-throughput screen identifies pharmacological agents that target neurotransmitter signaling in small cell lung carcinoma.. PloS one. 2011, 6 (9): e24132 [2019-12-21]. PMID 21931655. doi:10.1371/journal.pone.0024132.
Malchers, F; Ercanoglu, M; Schütte, D; Castiglione, R; Tischler, V; Michels, S; Dahmen, I; Brägelmann, J; Menon, R; Heuckmann, JM; George, J; Ansén, S; Sos, ML; Soltermann, A; Peifer, M; Wolf, J; Büttner, R; Thomas, RK. Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017-09-15, 23 (18): 5527–5536 [2019-12-21]. PMID 28630215. doi:10.1158/1078-0432.CCR-17-0478. （原始内容存档于2019-12-21）.

nih.gov

ncbi.nlm.nih.gov

Kajimoto, S; Horie, M; Manabe, H; Masuda, Y; Shibayama-Imazu, T; Nakajo, S; Gong, XF; Obama, T; Itabe, H; Nakaya, K. A tyrosine kinase inhibitor, beta-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity.. Biochimica et biophysica acta. 2008-01, 1782 (1): 41–50 [2019-12-21]. PMID 18078828. doi:10.1016/j.bbadis.2007.11.004. （原始内容存档于2019-12-21）.
Pettengill, OS; Sorenson, GD; Wurster-Hill, DH; Curphey, TJ; Noll, WW; Cate, CC; Maurer, LH. Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung.. Cancer. 1980-03-01, 45 (5): 906–18 [2019-12-21]. PMID 6266631. doi:10.1002/1097-0142(19800301)45:5<906::aid-cncr2820450513>3.0.co;2-h. （原始内容存档于2019-12-21）.
Improgo, MR; Johnson, CW; Tapper, AR; Gardner, PD. Bioluminescence-based high-throughput screen identifies pharmacological agents that target neurotransmitter signaling in small cell lung carcinoma.. PloS one. 2011, 6 (9): e24132 [2019-12-21]. PMID 21931655. doi:10.1371/journal.pone.0024132.
Malchers, F; Ercanoglu, M; Schütte, D; Castiglione, R; Tischler, V; Michels, S; Dahmen, I; Brägelmann, J; Menon, R; Heuckmann, JM; George, J; Ansén, S; Sos, ML; Soltermann, A; Peifer, M; Wolf, J; Büttner, R; Thomas, RK. Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017-09-15, 23 (18): 5527–5536 [2019-12-21]. PMID 28630215. doi:10.1158/1078-0432.CCR-17-0478. （原始内容存档于2019-12-21）.

pubmed.ncbi.nlm.nih.gov

Kajimoto, S; Horie, M; Manabe, H; Masuda, Y; Shibayama-Imazu, T; Nakajo, S; Gong, XF; Obama, T; Itabe, H; Nakaya, K. A tyrosine kinase inhibitor, beta-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity.. Biochimica et biophysica acta. 2008-01, 1782 (1): 41–50 [2019-12-21]. PMID 18078828. doi:10.1016/j.bbadis.2007.11.004. （原始内容存档于2019-12-21）.
Pettengill, OS; Sorenson, GD; Wurster-Hill, DH; Curphey, TJ; Noll, WW; Cate, CC; Maurer, LH. Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung.. Cancer. 1980-03-01, 45 (5): 906–18 [2019-12-21]. PMID 6266631. doi:10.1002/1097-0142(19800301)45:5<906::aid-cncr2820450513>3.0.co;2-h. （原始内容存档于2019-12-21）.
Malchers, F; Ercanoglu, M; Schütte, D; Castiglione, R; Tischler, V; Michels, S; Dahmen, I; Brägelmann, J; Menon, R; Heuckmann, JM; George, J; Ansén, S; Sos, ML; Soltermann, A; Peifer, M; Wolf, J; Büttner, R; Thomas, RK. Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017-09-15, 23 (18): 5527–5536 [2019-12-21]. PMID 28630215. doi:10.1158/1078-0432.CCR-17-0478. （原始内容存档于2019-12-21）.

web.archive.org

Kajimoto, S; Horie, M; Manabe, H; Masuda, Y; Shibayama-Imazu, T; Nakajo, S; Gong, XF; Obama, T; Itabe, H; Nakaya, K. A tyrosine kinase inhibitor, beta-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity.. Biochimica et biophysica acta. 2008-01, 1782 (1): 41–50 [2019-12-21]. PMID 18078828. doi:10.1016/j.bbadis.2007.11.004. （原始内容存档于2019-12-21）.
Pettengill, OS; Sorenson, GD; Wurster-Hill, DH; Curphey, TJ; Noll, WW; Cate, CC; Maurer, LH. Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung.. Cancer. 1980-03-01, 45 (5): 906–18 [2019-12-21]. PMID 6266631. doi:10.1002/1097-0142(19800301)45:5<906::aid-cncr2820450513>3.0.co;2-h. （原始内容存档于2019-12-21）.
Malchers, F; Ercanoglu, M; Schütte, D; Castiglione, R; Tischler, V; Michels, S; Dahmen, I; Brägelmann, J; Menon, R; Heuckmann, JM; George, J; Ansén, S; Sos, ML; Soltermann, A; Peifer, M; Wolf, J; Büttner, R; Thomas, RK. Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017-09-15, 23 (18): 5527–5536 [2019-12-21]. PMID 28630215. doi:10.1158/1078-0432.CCR-17-0478. （原始内容存档于2019-12-21）.